Details for New Drug Application (NDA): 087446
✉ Email this page to a colleague
NDA 087446 describes CHLOROPROCAINE HYDROCHLORIDE, which is a drug marketed by Hikma and Hospira and is included in three NDAs. It is available from one supplier. Additional details are available on the CHLOROPROCAINE HYDROCHLORIDE profile page.
The generic ingredient in CHLOROPROCAINE HYDROCHLORIDE is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.
The generic ingredient in CHLOROPROCAINE HYDROCHLORIDE is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.
Summary for 087446
| Tradename: | CHLOROPROCAINE HYDROCHLORIDE |
| Applicant: | Hospira |
| Ingredient: | chloroprocaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3% | ||||
| Approval Date: | Apr 16, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
